ID:22346025 Armin Zahid “The Role of Pharma Industry”

 




"The Role of Pharma Industry"




The pharma industry is defined as the discovery, development, and manufacturer of drugs and medications. This sector supports millions of jobs worldwide in addition to being crucial for its patients and communities. From creating a novel molecule to giving the correct dosage of medicine, this sector aids in the treatment and prevention of diseases. Currently, the pharmaceutical industry is facing significant challenges. This include decrease in new medical entities, increasing regulations, risk perceptions among society, and problems with reimbursement. As a result of Mergers and cost-cutting measures have been taken by pharmaceutical companies to fill their portfolios.

 

Since the very beginning, organic chemistry has been a significant contributor to the creation of new drugs. The first synthetic drug, nitroglycerine, was developed in 1844( Kueckmann, 2011). After the separation and identification of the pure chemical constituents of natural medicines were done, the synthetic drug industry developed. This was the first step toward organic chemistry. Ever since, organic chemistry has become more prominent and important in a wide range of disease areas because of its focus on medicinal chemistry. This was the first step toward organic chemistry. Ever since, organic chemistry has become more prominent and important in a wide range of disease areas because of its focus on medicinal chemistry.

 



The future of pharmacy is being changed by unprecedented growth, which is causing disruption throughout the health care supply chain. Clinical and technological advancements are happening at an unprecedented rate. Finding new cures for presently incurable diseases is one of the challenges the pharmaceutical industry has been facing. The industry has traditionally struggled to find treatments for diseases like cancer, Alzheimer's, and Epilepsy that are now incurable. There are very few instant fixes, and research and development take time. But developing new and innovative solutions requires continuous investment. Without it, the goal of discovering cures that work well enough will be difficult to achieve.

 

There are many diseases or syndromes that are still not curable. According to Kueckmann (2011), There are approximately 6,000 potential drug targets in the human genome, but only 300 are currently being addressed. Some of the diseases that still haven't been addressed are cancer, stroke, heart disease, epilepsy, malignant melanoma, and Alzheimer's. Malignant melanoma, ovarian, pancreatic, and small-cell lung cancer are also some examples of diseases with few or no treatment options. Infectious disorders, which are once again on the rise, are still another example. These include cardiovascular (stroke, heart failure, atrial fibrillation), neurological (Alzheimer's, Parkinson's, multiple sclerosis), women's health (endometriosis, myxoma), and neurodegenerative diseases (e.g., multi-resistant bacteria, new flu viruses).Products that prevent sickness rather than treat it require more time to prove their viability. The public needs to understand what it takes to develop new drugs and be patient about it.




But little research is being done by large pharmaceutical companies because money is not being spent on it. This lack of innovation can easily be seen in the health system. As a result, the amount of money spent on drugs is increasing far faster than health budgets as a whole. While innovation may undoubtedly advance the pharmacy profession, it can also alienate current practitioners, young professionals, the general public, insurance companies, other healthcare team members, and other important stakeholders. But to meet the challenges, including the lack of appreciation of the professional and clinical training of pharmacy graduates and the role they play in drug therapy and the health of society, innovation could re-energize the profession and address key barriers, which will advance the profession and its practitioners.

 

In conclusion, government, industry, and universities play a very vital role in marketing new drugs. Industries like pharmaceutical companies should focus on it’s research and give freedom to scientists so they can show their creativity and operational efficiency in all the areas of drug discovery and development. But organizations can't resolve or fund this on their own. So a collaboration between industries and national and non-governmental research organizations can create a strong global network, which will help increase the scientific base. Academic institutions should provide cutting-edge basic science while also being willing to collaborate with industry on applied research activities.

 

Reference:
 Kueckmann, T. (2011). The importance of chemistry for the future of Pharma industry
https://www.chemistryviews.org/details/ezine/1311499/The_Importance_of_Chemistry_for_the_Future_of_the_Pharma_Industry/

Sergent,  2022). Pharmacy Federal Rules and Regulations. StatPearls .

https://www.ncbi.nlm.nih.gov/books/NBK562220/

Comments

Popular posts from this blog

FEMINISM : What We Need To Know (Sanjida Islam-22346064)

Bone-forming Minerals

The Power of Forgiveness: How Letting Go of Resentment Can Improve Mental and Emotional Health(Arafat kabir_22346050)